Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-24 @ 11:19 PM
NCT ID:
NCT03105856
Eligibility Criteria:
Inclusion Criteria:
* Female aged 25 to 45 years at the time of the first vaccine dose.
* Willing to comply with the requirements of the protocol (e.g., return for follow-up visits).
* Written informed consent prior to enrollment.
Exclusion Criteria:
* Pregnant or breastfeeding. Women must be at least 3 months post-pregnancy and not breastfeeding to enter the study.
* Planning to become pregnant or planning to discontinue contraceptive precautions during the first twelve months of the study (months 0-12).
* History of allergic disease, suspected allergy or reactions likely to be exacerbated by any component of the vaccine.
* Any other medical condition or disease that could compromise the life of the participant during enrollment in the study.
* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccines within 30 days prior to the first dose of the study vaccine.
* Previous vaccination against human papillomavirus.
* History of cervical cancer or hysterectomy.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
25 Years
Maximum Age:
45 Years
Study:
NCT03105856
Study Brief:
Protocol Section:
NCT03105856